** Proteomics International Laboratories PIQ.AX jumps as much as 9.5% to A$0.810, highest since Oct. 11
** Medical technology firm says its OxiDx test - a finger-prick blood test to measure oxidative stress - accurately identifies muscle damage in marathon runners
** PIQ sets sights on H1 CY25 for Australian commercial launch of OxiDx test
** More than 540,000 shares traded, 5x the 30-day avg
** Stock trims YTD losses to 12.3%
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.